Project IMPACT Immunizations (IMProving America's Communities Together)
| Status: | Completed |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/13/2016 |
| Start Date: | October 2015 |
| End Date: | July 2016 |
The primary objective of this study is to evaluate how implementing an innovative care model
that provides the pharmacist access to a patient's vaccine history at the point-of-care
impacts the pharmacist's ability to identify unmet vaccination needs and increase
vaccination rates for routinely recommended adult vaccinations.
that provides the pharmacist access to a patient's vaccine history at the point-of-care
impacts the pharmacist's ability to identify unmet vaccination needs and increase
vaccination rates for routinely recommended adult vaccinations.
This is a multi-site, observational study investigating the impact of implementing an
innovative care model on the pharmacist's ability to identify unmet vaccination needs and
increase vaccination rates for routinely recommended adult vaccinations. The innovative care
model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination
histories, identify unmet vaccination needs, and document the care provided. Data will be
collected in the bi-directional IIS. Aggregate de-identified data will be reported to the
researchers at the midpoint and conclusion of the study. The project duration has been
established to allow sufficient time for each pharmacy to implement the innovative care
model and monitor each pharmacy for a 6-month study period. The American Pharmacists
Association (APhA) Foundation has an a priori intent to publish the project results.
innovative care model on the pharmacist's ability to identify unmet vaccination needs and
increase vaccination rates for routinely recommended adult vaccinations. The innovative care
model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination
histories, identify unmet vaccination needs, and document the care provided. Data will be
collected in the bi-directional IIS. Aggregate de-identified data will be reported to the
researchers at the midpoint and conclusion of the study. The project duration has been
established to allow sufficient time for each pharmacy to implement the innovative care
model and monitor each pharmacy for a 6-month study period. The American Pharmacists
Association (APhA) Foundation has an a priori intent to publish the project results.
Inclusion Criteria:
- Individuals eligible to be enrolled in the study include any person at least 18 years
of age receiving an influenza vaccination from a participating pharmacy site.
Exclusion Criteria:
We found this trial at
8
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials